Diamond Capital Management »

Cyclacel Pharmaceuticals shares owned by Diamond Capital Management

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals shares owned by Diamond Capital Management from 13F filings

Historical chart of Diamond Capital Management investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by Diamond Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by Diamond Capital Management

Quarter filed Position value Share count Share price at filing
2011-09-30 $14k 32k 0.44
2011-06-30 $44k 32k 1.37

More positions owned by Diamond Capital Management

Spdr S&p 500 Etf (SPY)
iShares MSCI Emerging Markets Indx (EEM)
iShares S&P 500 Index (IVV)
Utilities SPDR (XLU)
Vanguard Emerging Markets ETF (VWO)
Financial Select Sector SPDR (XLF)
Vanguard Large-Cap ETF (VV)
Industrial SPDR (XLI)
Consumer Staples Select Sect. SPDR (XLP)
SPDR Dow Jones Industrial Average ETF (DIA)
Energy Select Sector SPDR (XLE)
Procter & Gamble Company (PG)
Microsoft Corporation (MSFT)
Technology SPDR (XLK)
Cisco Systems (CSCO)

View all positions for Diamond Capital Management